Northwest Biotherapeutics Inc Cash Flow Statement

Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -22.75M-34.44M-57.27M-56.32M-102.14M-130.44M-83.08M-60.22M-51.35M-30.95M-95.15M-57.71M-73.25M-60.75M-74.28M
Depreciation and Depletion 0.01M0.06M0.19M0.40M1.30M0.02M0.09M0.30M1.30M1.50M1.70M
Share-based Compensation 2.62M4.56M10.93M3.69M2.34M21.33M40.77M13.65M0.84M14.14M1.82M52.21M15.50M12.30M4.41M3.46M
Gains from Investment Securities 3.28M0.36M
Cash from Restructuring -0.05M
Non-cash Items 29.79M5.22M28.59M0.26M-6.94M497.76M-220.15M45.05M12.66M16.76M
Cash from Operations -4.68M-6.38M-14.71M-22.75M-37.80M-54.58M-79.71M-55.65M-36.49M-34.59M-31.86M-32.09M-38.30M-52.77M-53.64M-57.02M
Depreciation, Depletion & Amortization
Amortization of Goodwill 0.39M-0.94M2.44M
Amortizatization of Intangibles 4.51M6.02M14.02M0.53M0.06M0.85M1.52M-0.32M0.65M
Amortization of Deferred Charges 19.70M0.21M1.25M1.52M6.71M1.43M3.01M2.30M2.77M2.37M2.48M
Depreciation & Amortization (CF) 0.00M0.01M0.01M0.01M0.01M0.06M0.19M0.44M1.29M0.02M0.09M0.32M1.25M1.52M1.74M
Change in Working Capital
Change in Accured Expenses 4.62M1.36M15.07M13.75M19.34M3.05M17.90M7.70M4.00M-3.23M1.70M-0.67M3.49M-4.48M8.94M
Other Working Capital Changes 0.33M0.21M0.03M0.14M0.24M0.06M
Investing Activities
Capital Expenditures 0.04M0.05M0.03M-0.00M33.73M6.75M4.94M0.01M0.36M6.61M6.01M2.90M3.44M1.01M
Sales of Property, Plant and Equipment 0.26M45.59M
Acquisitions 1.53M
Change in Acquisitions & Divestments 2.00M
Cash from Investing Activities -0.00M-0.04M-0.05M-0.03M0.00M-36.35M-6.75M-4.94M0.21M45.40M-0.36M-8.14M-6.01M-2.90M-3.44M-1.01M
Financing Activities
Other financing activities 0.48M3.96M0.62M0.14M1.08M0.14M0.11M
Cash from Financing Activities 4.75M6.61M14.62M30.15M48.95M85.82M93.95M38.31M34.29M7.87M9.95M52.70M48.13M41.97M52.76M56.78M
Debt Issuance and Repayment
Current Debt -6.70M-7.60M-0.45M-8.05M
Net Debt Issuances and Repayments -6.70M-7.60M-0.45M-8.05M
Change in Capital Stock
Net Equity Issued and Repurchased 5.30M
Dividend Payments
Dividends Paid - Common -1.25M
Additional items
Exchange Rate Effect -0.03M-0.10M0.00M-0.04M-0.46M6.11M-4.76M3.42M0.41M-2.85M1.37M5.50M-0.52M1.29M
Change in Cash 0.09M-0.13M7.32M11.15M-5.11M7.03M-16.18M-6.75M22.11M-21.85M9.61M5.19M-8.20M-4.84M0.05M
Beginning Cash Balance 0.07M0.07M0.15M0.02M7.35M18.50M14.78M23.05M6.87M0.12M22.22M0.37M9.98M15.17M6.96M2.13M
Free Cash Flow -4.68M-6.42M-14.76M-22.79M-37.80M-88.30M-86.46M-60.59M-36.50M-34.59M-32.22M-38.70M-44.31M-55.68M-57.07M-58.03M
Net Cash Flow 0.07M0.19M-0.13M7.36M11.15M-5.11M7.49M-22.28M-1.99M18.69M-22.27M12.46M3.82M-13.71M-4.32M-1.25M